CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Operating activities
Net income (loss)	$ (32,458)	$ 22,803
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	75,474	62,379
Amortization of share-based compensation	5,173	5,907
Live inventory adjustment (net of prior period reversal)	(2,800)	(9,600)
Provision for losses (recoveries) on accounts receivable	0	(1,500)
Deferred income taxes	57,256	6,699
Gain (Loss) on Disposition of Assets	238	0
Change in assets and liabilities:
Accounts receivable - trade	(294)	(3,457)
Accounts receivable - insurance	445	1,111
Income taxes	(120,760)	27,363
Inventories	(4,749)	(35,817)
Prepaid expenses and other assets	(6,242)	(9,160)
Right of use assets	8,733	0
Lease liabilities	(8,733)	0
Accounts payable	(8,159)	(10,738)
Accrued expenses and other liabilities	(353)	(6,193)
Total adjustments	(4,771)	26,994
Net cash provided by (used in) operating activities	(37,229)	49,797
Investing activities
Capital expenditures	(129,691)	(162,268)
Net proceeds from sale of property and equipment	207	880
Net cash used in investing activities	(129,484)	(161,388)
Financing activities
Payment of debt issuance costs	0	(2,225)
Borrowings from revolving line of credit	145,000	100,000
Proceeds from issuance of restricted stock under stock compensation plans	600	479
Payments from issuance of common stock under stock compensation plans	(5,861)	(3,829)
Dividends paid	(7,113)	(7,089)
Net cash provided by financing activities	132,626	87,336
Net change in cash and cash equivalents	(34,087)	(24,255)
Cash and cash equivalents at beginning of period	95,417	121,193
Cash and cash equivalents at end of period	61,330	96,938
Supplemental disclosure of non-cash investing and financing activities:
Capital expenditures included in accounts payable	5,588	5,174
Dividends payable	$ 7,117	$ 7,089